Navigation Links
Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
Date:11/6/2012

TOKYO and SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation (Ambit) today announced that five oral presentations and three poster presentations highlighting the findings from multiple clinical and translational research studies with the investigational agent, quizartinib (AC220), will be presented at the American Society of Hematology (ASH) 54thAnnual Meeting, December 8 - 11, 2012, at the Georgia World Congress Center in Atlanta, Georgia.  The abstracts can be accessed through the ASH website, http://hematology.org./.

"The data being presented at ASH demonstrate the commitment of the Ambit-Astellas alliance in bringing new options to patients suffering from AML, and we are excited to share this breadth of data from multiple clinical studies," said Wayne Klohs, PhD, Senior Vice President, Oncology Therapeutic Area Head, Astellas Pharma Global Development, Inc.

Oral Presentations

  • Final Results of a Phase 2 Open-Label, Monotherapy Efficacy and Safety Study of Quizartinib (AC220) in Patients >/_60 Years of Age with FLT3 ITD Positive or Negative Relapsed/Refractory Acute Myeloid Leukemia (abstract #48) will be presented by MD Anderson's Jorge Cortes, M.D., at 1:15 p.m. EST on Sunday, December 9, in Room A101. The presentation will take place during the Acute Myeloid Leukemia –Therapy, excluding Transplantation: Novel Therapies oral session.
  • Final Results of a Phase 2 Open-Label, Monotherapy Efficacy and Safety Study of Quizartinib (AC220) in Patients with FLT3-ITD Positive or Negative Relapsed/Refractory Acute Myeloid Leukemia After Second-Line Chemotherapy or Hematopoietic Stem Cell Transplantation (abstract #673) will be presented by the Johns Hopkins University's Mark Levis, M.D., Ph.D., at 4:30
    '/>"/>

SOURCE Ambit Biosciences Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
2. Ambit Biosciences to Present at Two Upcoming Investor Conferences
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. AMRI Announces Third Quarter 2012 Results
5. Egenix, Inc. Announces New Director
6. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
7. WebMD Announces Third Quarter Financial Results
8. Life Technologies Announces Third Quarter 2012 Results
9. HealthTech Capital Announces Awards for the HealthTech Conference 2012 - Building a Business in the New HealthTech Ecosystem
10. Verenium Corporation To Announce Third Quarter 2012 Financial Results
11. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Ga. , Aug. 26, 2014  ViveBio, ... biological sample collection, stabilization and transportation, announced today ... Laboratory Procurement Services, LLC (LPS) of ... of products in the United States ... new class of ambient temperature dried biological specimen ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... WASHINGTON , Aug. 26, 2014 ... Next Generation Dx Summit; Moving Assays to ... "Targeted Detection and Monitoring of Cell Free Tumor ... the analytical component of its Precision Cancer Monitoring ... high clinical sensitivity for the detection of tumor ...
(Date:8/26/2014)... 2014  That,s Nice LLC, a research-focused strategic marketing ... formation of a new dedicated team that will support ... will combine current and new staff in both market ... Guy Tiene has been hired ... Tiene was previously Director of Marketing for Royal DSM,s ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... VPHM ) today announced that Vincent Milano, ... at the Thomas Weisel Partners,2008 Healthcare Conference at ... conference is being held at the Four Seasons ... that William Roberts, vice president,corporate communications of ViroPharma ...
... /PRNewswire/ - Enerkem Inc., a leading second,generation ... of,two new Vice-Presidents to its executive team: ... Mrs. Marie-Helene Labrie,Vice-President, Government Affairs and Communications., ... seasoned executives to our management,team," said Mr. ...
... NV,(Euronext Brussels: THR), a biotechnology company focused on ... is today issuing a,business update and its financial ... 2008., During the first half of 2008, ... have positioned the Company to successfully pursue the,next ...
Cached Biology Technology:ViroPharma to Present at Three September Healthcare Conferences 2Enerkem Expands Executive Management Team 2ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5
(Date:8/26/2014)... developed algorithms to identify weak spots in tendons, muscles ... which needs to be refined before it is used ... and tiny injuries in the body,s tissues long before ... Aug. 27 in the Journal of the Royal ... of the physical and life sciences. , "Tendons are ...
(Date:8/26/2014)... from policymakers, consumers, and suppliers has prompted manufacturers ... the pollutants they emit from their smokestacks or ... also assess environmental performance at every step in ... to the use and recycling of their products. ... discipline known as life cycle engineering, which connects ...
(Date:8/26/2014)... importance of enteral nutrition (EN), or feeding patients through ... understood, underfeeding is still common. A practice of a ... by tests, procedures, or emergencies. Changing to a volume-based ... day, could reduce underfeeding. , Such a system was ... a quality improvement audit published in the American Society ...
Breaking Biology News(10 mins):New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Yale journal explores advances in sustainable manufacturing 2
... Ice Age, as the world began to warm, a swath ... brief pulse of biological productivity 14,000 years ago, this stretch ... tiny creatures, who thrived in large numbers until the productivity ... Researchers have hypothesized that iron sparked this surge ...
... atmospheric carbon dioxide, forests over the last two decades ... water, a Harvard study has found. Studies ... water more efficiently as atmospheric carbon dioxide levels rose. ... and Assistant Professor of Organismic and Evolutionary Biology Andrew ...
... at the Center for Infection and Immunity at Columbia University,s ... new virus associated with the death of a short-beaked dolphin ... the first time that a virus belonging to the polyomavirus ... in the journal PLOS ONE . Polyomavirus is ...
Cached Biology News:Scientists solve a 14,000-year-old ocean mystery 2Scientists solve a 14,000-year-old ocean mystery 3Efficiency in the forest 2Efficiency in the forest 3New virus discovered in stranded dolphin 2
NATIVE RAT OSTEOCALCIN...
Form: Ready to use Applications: ELISA...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Wnt-1 (G-19)...
Biology Products: